Imipenem for treatment of relapsing Salmonella meningitis in a newborn infant.
Salmonella meningitis is a rare clinical entity that occurs mainly during early infancy. Treatment of Salmonella infections may be complicated by the bacteria's growing resistance to clinically important antimicrobial agents, especially third-generation cephalosporins. A report is presented of a newborn infant with Salmonella meningitis who relapsed after 4 weeks of cefotaxime treatment and was cured completely with imipenem cilastatin therapy.
Koç
E
E
Department of Pediatrics, Gazi University Faculty of Medicine, Ankara, Turkey.
Turkyilmaz
C
C
Atalay
Y
Y
Sen
E
E
D018550:Cephalosporin Resistance; D006801:Humans; D015378:Imipenem / Q000627:therapeutic use*; D007231:Infant, Newborn; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy*; D012008:Recurrence; D012480:Salmonella Infections / Q000188:drug therapy*; D012482:Salmonella paratyphi A; D013845:Thienamycins / Q000627:therapeutic use*
D013845:Thienamycins; D015378:Imipenem